John Alam

Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.

Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.

The Accelerated Cure Project for Multiple Sclerosis cures multiple sclerosis (MS) by determining the cause. It specializes in research, biobanking, collaboration, fundraising, nonprofit. The company was founded by Art Mellor in 2000 and is headquartered in Waltham, MA.

International School of Boston, Inc. engages in the provision of rigorous bilingual French-American education. It provides preschool and kindergarten; lower school; middle school; upper school; college counseling; art department; and student support. The company was founded in 1962 and is headquartered in Cambridge, MA.

EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA.